Company Filing History:
Years Active: 2015
Title: The Innovative Contributions of Michael Schaefer
Introduction
Michael Schaefer, an accomplished inventor based in St. Louis, MO, has made significant contributions to the field of pharmacology through his innovative work. With a strong background in chemistry and a passion for developing new processes, Schaefer has successfully obtained a patent that addresses the preparation of normorphinans. This advancement has the potential to impact various applications within the medical and pharmaceutical industries.
Latest Patents
Schaefer holds a notable patent titled "Preparation of normorphinans." This invention outlines processes for preparing normorphinans from N-substituted morphinans. Specifically, the patent describes methods for removing the N-substituent from the N-substituted morphinan to create a normorphinan carbamate, and subsequently eliminating the carbamate functionality to yield the final normorphinan. This patented process reflects Schaefer’s expertise in the field and his commitment to innovative solutions.
Career Highlights
Michael Schaefer is currently employed at Mallinckrodt, Inc., a well-regarded company specializing in the manufacturing of specialty pharmaceuticals and medical products. His role within the organization has allowed him to leverage his skills and knowledge in chemistry to advance novel pharmaceutical processes. Schaefer's dedication to research and development has paved the way for future innovations in the medical field.
Collaborations
Throughout his career, Schaefer has collaborated with talented colleagues such as John Brandt and Subo Liao. These partnerships exemplify the collaborative spirit often found in research and innovation efforts, allowing for the exchange of ideas that drive the field forward. These collaborations have likely played a key role in enhancing the quality and scope of his work.
Conclusion
Michael Schaefer stands out as a prominent figure in the realm of innovation, particularly within the pharmaceutical industry. His patented processes for preparing normorphinans highlight his ability to create impactful solutions. As he continues to work at Mallinckrodt, Inc., it will be exciting to see how his contributions will further advance the field and potentially improve patient outcomes.